Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

This summary covers recent health news, including the slow adoption of gene therapy for sickle cell, Glenview Capital's ...

Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...

Global Next-generation Sequencing Services Market is valued at approximately USD 4.80 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 22.68% over the forecast period ...

Current health news includes the declaration of a public health emergency in Georgia due to Hurricane Helene, the slow uptake ...

September is sickles cell awareness month. One Chicago woman who was diagnosed at birth is raising funds and awareness with a ...

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.